Orthofix Medical Inc. (OFIX) stock
OFIXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 23
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 10/3051% below fair value
$6.94−0.24 (-3.34%)
Close on Nov 12, 2026Market cap $282.68MP/E –Yield –
Orthofix Medical gross margin
Gross margin is gross profit as a percentage of revenue.
Orthofix Medical's gross margin for the twelve months ending Sep 30, 2026 was 70.9%. For fiscal 2025 it was 68.8%, against 68.3% the year before. The highest annual figure on record is 79.0% in fiscal 2010.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 68.8% | +0.6 |
| FY2024 | Dec 31, 2024 | 68.3% | +3.2 |
| FY2023 | Dec 31, 2023 | 65.1% | −8.1 |
| FY2022 | Dec 31, 2022 | 73.2% | −2.1 |
| FY2021 | Dec 31, 2021 | 75.3% | +0.3 |
| FY2020 | Dec 31, 2020 | 74.9% | −3.2 |
| FY2019 | Dec 31, 2019 | 78.1% | −0.5 |
| FY2018 | Dec 31, 2018 | 78.7% | +0.1 |
| FY2017 | Dec 31, 2017 | 78.6% | −0.0 |
| FY2016 | Dec 31, 2016 | 78.6% | +0.4 |
| FY2015 | Dec 31, 2015 | 78.2% | +2.8 |
| FY2014 | Dec 31, 2014 | 75.4% | +2.3 |
| FY2013 | Dec 31, 2013 | 73.1% | −4.0 |
| FY2012 | Dec 31, 2012 | 77.1% | −0.7 |
| FY2011 | Dec 31, 2011 | 77.9% | −1.1 |
| FY2010 | Dec 31, 2010 | 79.0% | +4.4 |
| FY2009 | Dec 31, 2009 | 74.6% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 70.5% | −1.7 |
| Q2 FY2026 | Jun 30, 2026 | 71.0% | +2.3 |
| Q1 FY2026 | Mar 31, 2026 | 70.9% | +8.1 |
| Q4 FY2025 | Dec 31, 2025 | 71.1% | +2.1 |
| Q3 FY2025 | Sep 30, 2025 | 72.2% | +3.5 |
| Q2 FY2025 | Jun 30, 2025 | 68.7% | +0.9 |
| Q1 FY2025 | Mar 31, 2025 | 62.8% | −4.7 |
| Q4 FY2024 | Dec 31, 2024 | 69.0% | +0.8 |
| Q3 FY2024 | Sep 30, 2024 | 68.7% | +3.6 |
| Q2 FY2024 | Jun 30, 2024 | 67.8% | +3.9 |
| Q1 FY2024 | Mar 31, 2024 | 67.5% | +4.5 |
| Q4 FY2023 | Dec 31, 2023 | 68.2% | −4.8 |
| Q3 FY2023 | Sep 30, 2023 | 65.1% | −8.1 |
| Q2 FY2023 | Jun 30, 2023 | 63.9% | −9.3 |
| Q1 FY2023 | Mar 31, 2023 | 63.0% | −10.4 |
| Q4 FY2022 | Dec 31, 2022 | 73.0% | −0.5 |
| Q3 FY2022 | Sep 30, 2022 | 73.2% | −1.6 |
| Q2 FY2022 | Jun 30, 2022 | 73.2% | −4.2 |
| Q1 FY2022 | Mar 31, 2022 | 73.4% | −2.1 |
| Q4 FY2021 | Dec 31, 2021 | 73.4% | −1.9 |
| Q3 FY2021 | Sep 30, 2021 | 74.8% | −1.5 |
| Q2 FY2021 | Jun 30, 2021 | 77.4% | +9.1 |
| Q1 FY2021 | Mar 31, 2021 | 75.5% | −2.2 |
| Q4 FY2020 | Dec 31, 2020 | 75.3% | −3.2 |
| Q3 FY2020 | Sep 30, 2020 | 76.4% | −1.7 |
| Q2 FY2020 | Jun 30, 2020 | 68.3% | −9.4 |
| Q1 FY2020 | Mar 31, 2020 | 77.7% | −0.6 |
| Q4 FY2019 | Dec 31, 2019 | 78.4% | −0.4 |
| Q3 FY2019 | Sep 30, 2019 | 78.1% | −0.4 |
| Q2 FY2019 | Jun 30, 2019 | 77.7% | −1.8 |
| Q1 FY2019 | Mar 31, 2019 | 78.3% | +0.5 |
| Q4 FY2018 | Dec 31, 2018 | 78.8% | −1.0 |
| Q3 FY2018 | Sep 30, 2018 | 78.5% | +1.0 |
| Q2 FY2018 | Jun 30, 2018 | 79.5% | +0.8 |
| Q1 FY2018 | Mar 31, 2018 | 77.8% | −0.2 |
| Q4 FY2017 | Dec 31, 2017 | 79.8% | +1.3 |
| Q3 FY2017 | Sep 30, 2017 | 77.5% | – |
| Q2 FY2017 | Jun 30, 2017 | 78.7% | – |
| Q1 FY2017 | Mar 31, 2017 | 78.0% | – |
| Q4 FY2016 | Dec 31, 2016 | 78.5% | – |
See a number that looks wrong?